Qualigen Therapeutics Ownership | Who Owns Qualigen Therapeutics?
Qualigen Therapeutics Ownership Summary
Qualigen Therapeutics is owned by 5.66% institutional investors, and 94.34% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.13% of its assets in Qualigen Therapeutics shares.
QLGN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Qualigen Therapeutics | 5.66% | - | 94.34% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 36.43K | 0.13% | 16.52K |
Vanguard Institutional Extnd Mkt Idx Tr | 22.83K | 0.08% | - |
Fidelity Nasdaq Composite Index | 4.89K | 0.02% | - |
SSgA U.S. Extended Market Index Class I | 4.14K | 0.02% | - |
State St US Extended Mkt Indx NL Cl C | 4.14K | 0.02% | - |
Fidelity Series Total Market Index | 2.92K | 0.01% | - |
NT Ext Equity Mkt Idx Fd - L | 2.11K | 0.01% | - |
Northern Trust Extended Eq Market Idx | 2.11K | 0.01% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.93K | 0.01% | - |
SSgA U.S. Total Market Index Strategy | 1.70K | 0.01% | 504.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 22, 2022 | Poirier Michael S. | Chairman and CEO | Buy | $17.10K |
Jun 14, 2022 | BROIDRICK AMY S. | President/CSO | Buy | $18.60K |
Aug 19, 2021 | Kruger Kurt H | - | Buy | $4.88K |
Aug 19, 2021 | Kruger Kurt H | - | Buy | $4.92K |
Apr 26, 2021 | BROIDRICK AMY S. | EVP, Chief Strategy Officer | Buy | $9.13K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2022 Q3 | - | - |
2022 Q2 | 2 | - |
2021 Q4 | - | - |
2021 Q3 | 2 | - |
2021 Q2 | 3 | - |
QLGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools